Biopharmaceutical Supply Chains

Rob Handfield is the Bank of America University Distinguished Professor of Supply Chain Management at North Carolina State University, and Director of the Supply Chain Resource Cooperative (http://scm.ncsu.edu). He also serves as an Adjunct Professor with the Supply Chain Management Research Group at the Manchester Business School. He received his PhD in Operations Management from the University of North Carolina at Chapel Hill, and a BSc in Applied Math from the University of British Columbia.The SCRC is the first major industry-university partnership to integrate student projects into the MBA classroom in an integrative fashion, and has had 15 major Fortune 500 companies participating as industry partners since 1999. Prior to this role, Handfield was an Associate Professor and Research Associate with the Global Procurement and Supply Chain Benchmarking Initiative at Michigan State University from 1992-1999, working closely with Professor Robert Monczka.Handfield is the Consulting Editor of the Journal of Operations Management, one of the leading supply chain management journals in the field, and is the author of several books on supply chain management, the most recent being Supply Market Intelligence, Supply Chain Re-Design and Introduction to Supply Chain Management (Prentice Hall, 1999, 25,000 copies sold, and translated into Chinese, Japanese, and Korean). He has co-authored textbooks for MBA and undergraduate classes including Purchasing and Supply Chain Management 5th revision (with Robert Monczka) and Operations and Supply Chain Management 2nd revision (with Cecil Bozarth). Handfield is considered a thought leader in the field of supply chain management, and is an industry expert in the field of strategic sourcing, supply market intelligence, and supplier development. He has spoken on these subjects across the globe, including China, Azerbaijan, Turkey, Latin America, Europe, Korea, Japan, Canada, and other venues.

• Key Forces Driving the Biopharma Supply Chain. Challenges in the Clinical Supply Chain. Regulatory Trends. The Race to the Bed Side, Specific to Hospitals. Industry Reactions to Evolving Distribution Models. The Path Forward for the Industry.

"Handfield provides insights into the need for patient-centric value chain collaboration, and is a must-read for manufacturers, wholesalers, and payor/providers in the biopharmaceutical industry"—Robert Lechich, Director of Operational Excellence, Pfizer Corporation"Handfield challenges our current and arguably provincial notions of supply chain commonly held in the biopharmaceutical industry and forces us to really see it for what it is—a process that ultimately connects the initial product manufacturing process directly to the patient and all points in between. His systemic approach dismantles various paradigm silos to reveal a complex series of interconnected activities and players, demonstrating a dynamic whole and clearer view to making the current healthcare debate more meaningful."—Bill Welsh, PhD, Associate Director, Strategic Programs, Golden LEAF Biomanufacturing Training & Education Center, North Carolina State University, Raleigh, USA